LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 201 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $816,590 | +20.0% | 13,628 | +44.4% | 0.00% | – |
| Q2 2023 | $680,409 | +235.2% | 9,437 | +314.8% | 0.00% | – |
| Q2 2022 | $203,000 | -30.0% | 2,275 | -11.5% | 0.00% | – |
| Q1 2022 | $290,000 | -26.0% | 2,572 | +1.2% | 0.00% | – |
| Q4 2021 | $392,000 | +19.5% | 2,541 | +8.2% | 0.00% | – |
| Q3 2021 | $328,000 | +60.8% | 2,349 | +50.8% | 0.00% | – |
| Q2 2021 | $204,000 | -8.5% | 1,558 | +6.9% | 0.00% | – |
| Q1 2021 | $223,000 | – | 1,458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |